AstraZeneca

Showing 15 posts of 785 posts found.

AstraZeneca's Nexium (esomeprazole)

Job cuts at AstraZeneca’s US manufacturing plant

May 24, 2011
Manufacturing and Production AstraZeneca, job cuts

AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …

GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011
Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …

GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011
Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …

AZ signs targeted colon cancer drug collaboration

May 11, 2011
Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …

AZ gets green light for thyroid cancer drug

April 7, 2011
Sales and Marketing AstraZeneca, zactima

AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …

AstraZeneca pays $1.1bn to resolve tax affairs

March 31, 2011
Sales and Marketing AstraZeneca, tax

AstraZeneca has sorted out a decade-long dispute over its tax affairs by agreeing to pay out $1.1 billion this year. …

Bayer-helmed oncology biomarker project launched

March 14, 2011
Manufacturing and Production, Research and Development AstraZeneca, Bayer, Janssen, Max Planck Institute, Merck, OncoTrack, Pfizer, Roche, biomarkers, oncology

A project to develop the next generation of oncology biomarkers has been launched in Berlin. The pharma industry and European …

AstraZeneca

AZ partners with Galderma on psoriasis research

March 9, 2011
Research and Development AZ, AstraZeneca, Galderma, dermatology, psoriasis

AstraZeneca has signed a five-year deal with dermatology specialist Galderma Pharma to develop new treatments for conditions including psoriasis. It …

AZ stops making Pulmicort pMDI inhaler

March 8, 2011
Manufacturing and Production AZ, AstraZeneca, Pulmicort, Pulmicort pMDI, Skyepharma, asthma, asthma inhaler, budesonide

AstraZeneca has discontinued production of its Pulmicort pMDI asthma inhaler because of manufacturing issues, and looks set to exit from …

Onglyza expands European licence

March 4, 2011
Sales and Marketing AZ, AstraZeneca, BMS, Bristol-Myers Squibb, Onglyza, diabetes, renal impairment, saxagliptin, type II diabetes

European regulators have approved a licence extension for diabetes treatment Onglyza, making it the first drug in its class that …

AZ opens new global HQ in London

February 28, 2011
Medical Communications, Sales and Marketing AZ, AstraZeneca, London

AstraZeneca has moved its London global headquarters from Mayfair to new, larger premises in Paddington. The new offices are located …

AstraZeneca plans $150m plant in Russia

February 22, 2011
Manufacturing and Production, Sales and Marketing AstraZeneca, Russia, emerging pharma markets, pharma manufacturing

AstraZeneca has become the latest drugmaker to announce the construction of a manufacturing facility in Russia to help sidestep possible …

AZ accepts $92.5m to settle respiratory dispute

February 18, 2011
Sales and Marketing AZ, AstraZeneca, MedImmune, PDL BioPharma, Synagis, patent dispute, respiratory

AstraZeneca’s MedImmune subsidiary is to receive $92.5 million as part of a legal settlement involving its respiratory drug Synagis. PDL …

AstraZeneca's social media white paper

Digital Pharma: AZ presses the case for social media in pharma

February 11, 2011
Medical Communications AZ, AstraZeneca, Digital Pharma blog, FDA, social media

Seemingly fed up with waiting for the FDA’s delayed social media guidance, AstraZeneca has published details of its own feedback …

Diabetes injection

Pharma-NHS diabetes project begins

February 9, 2011
Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working

A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …

The Gateway to Local Adoption Series

Latest content